Message #10 From:
Stock News Bot Date: September 25, 2006 07:20:00 AM
HBSC News Human BioSystems to Expand Into Larger Research Facility
PALO ALTO, Calif.--(BUSINESS WIRE)--Human BioSystems (OTCBB:HBSC) (“HBS”
or “Company”)
announced today that the Company signed a lease to move from its current
research facility in Vicksburg, Michigan to a larger facility in the
same city.
Dr. Luis Toledo, Chief Medical Officer for HBS said that, “All
of our organ preservation research studies were done here at our present
facility, but we are looking forward to moving to larger facilities to
accommodate additional equipment that will be needed to conduct our
freezing technology tests on Islet cells and to continue work on organs.”
HBS signed a five year lease to commence occupancy in December of 2006,
after improvements to the space are made to suit the Company’s
laboratory and office needs.
Human BioSystems is a developer of preservation platforms for organs,
platelets and other biomaterials. The Company, which is headquartered in
Palo Alto, California has research facilities in Michigan.
Certain statements contained herein are "forward-looking"
statements (as such term is defined in the Private Securities Litigation
Reform Act of 1995). Because such statements include risks and
uncertainties, actual results may differ materially from those expressed
or implied by such forward-looking statements. Factors that could cause
results to differ materially from those expressed or implied by such
forward-looking statements include, but are not limited to, results from
ongoing research and development as well as clinical studies, failure to
obtain regulatory approval for the Company’s
products, if required, failure to develop a product based on the Company’s
technology, failure of any such products to compete effectively with
existing products, the inability to find a strategic partner or to
consummate a relationship with a potential strategic partner on
acceptable terms, and other factors discussed in filings made by the
Company with the Securities and Exchange Commission
